Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Comparing high versus low electrical frequencies delivered through fine needles to improve shoulder muscle strength and pain sensitivity

Official title: Impact of Different Electrical Frequencies Used in Percutaneous Neuromodulation on Muscle Strength and Pressure Pain Thresholds

Run by Universidad Complutense de Madrid · NCT07269925 · Data updated 2026-11-12

This trial will test whether high- or low-frequency percutaneous electrical nerve stimulation using fine needles helps improve shoulder muscle strength and increases pressure-pain thresholds in people with shoulder pain and a latent trigger point in the infraspinatus.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment30 (estimated)
SponsorUniversidad Complutense de Madrid
Academic / other
Locations2 sites (Krakow, Poland and 1 other locations)
StatusRecruiting
StartedFebruary 15, 2026
Main results expectedJune 30, 2026
Study endsJuly 30, 2026
Registry record updatedMay 8, 2026
Trial IDNCT07269925 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with shoulder pain who have at least one latent myofascial trigger point in the infraspinatus muscle and can give informed consent.

Probably not a fit

People taking medications that affect muscle tone, those with neuropathies, prior shoulder/spine surgery, generalized pain disorders like fibromyalgia, or severe systemic illnesses are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with at least one latent myofascial trigger point in the infraspinatus will receive percutaneous electrical nerve stimulation delivered through fine filiform needles using either a high- or low-frequency protocol. Outcomes include objective measures of shoulder muscle strength and pressure pain thresholds measured before and after the intervention. Participants with interfering medications, prior shoulder or spine surgery, neuropathies, generalized pain syndromes, or major medical problems are excluded. The trial is conducted at clinical sites affiliated with the sponsoring Spanish universities and collaborating Polish clinics, addressing a gap in controlled comparisons of stimulation frequency for upper-limb musculoskeletal pain.

Why it matters

Potential benefit: If successful, the procedure could provide a non-pharmacologic way to increase shoulder muscle strength and reduce local pain sensitivity for some patients with myofascial trigger points.

How similar studies have gone: Previous small and single-case reports of percutaneous electrical nerve stimulation have reported pain and function improvements in some patients, but high-quality comparative evidence—especially on frequency differences in the upper limb—is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Presence of at least one latent myofascial trigger point (MTrP) in the infraspinatus muscle, identified according to the most recent Delphi consensus criteria.
* Ability to read, understand, and sign the written informed consent form.

Exclusion Criteria:

* Current pharmacological treatment that may affect muscle tone.
* History of shoulder or spinal surgery.
* Traumatic disorders such as whiplash-associated injuries, dislocations, or fractures.
* Neuropathies, including radiculopathies or myelopathies.
* Severe medical conditions (e.g., tumors, fractures, neurological or systemic diseases).
* Clinically relevant asymmetries.
* Generalized musculoskeletal conditions such as fibromyalgia.

Where it's running

  • Atmis
    Nowy Targ, Poland
    Recruiting
  • Atmis
    Krakow, Poland, Poland
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.